[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69131895D1 - Substituierte thiazol- und pyridinderivate - Google Patents

Substituierte thiazol- und pyridinderivate

Info

Publication number
DE69131895D1
DE69131895D1 DE69131895T DE69131895T DE69131895D1 DE 69131895 D1 DE69131895 D1 DE 69131895D1 DE 69131895 T DE69131895 T DE 69131895T DE 69131895 T DE69131895 T DE 69131895T DE 69131895 D1 DE69131895 D1 DE 69131895D1
Authority
DE
Germany
Prior art keywords
formula
alk
radical
substituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69131895T
Other languages
English (en)
Other versions
DE69131895T2 (de
Inventor
Eduard Janssens
Maria Sommen
Stanislas Diels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE69131895D1 publication Critical patent/DE69131895D1/de
Publication of DE69131895T2 publication Critical patent/DE69131895T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69131895T 1990-07-19 1991-07-09 Substituierte thiazol- und pyridinderivate Expired - Fee Related DE69131895T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55432590A 1990-07-19 1990-07-19
PCT/EP1991/001292 WO1992001697A1 (en) 1990-07-19 1991-07-09 Novel substituted thiazolyl and substituted pyridinyl derivatives

Publications (2)

Publication Number Publication Date
DE69131895D1 true DE69131895D1 (de) 2000-02-10
DE69131895T2 DE69131895T2 (de) 2000-07-20

Family

ID=24212925

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69131895T Expired - Fee Related DE69131895T2 (de) 1990-07-19 1991-07-09 Substituierte thiazol- und pyridinderivate

Country Status (27)

Country Link
EP (1) EP0539420B1 (de)
JP (1) JP3085707B2 (de)
KR (1) KR100206723B1 (de)
CN (1) CN1037770C (de)
AT (1) ATE188477T1 (de)
AU (1) AU646280B2 (de)
CA (1) CA2086546A1 (de)
CZ (1) CZ279903B6 (de)
DE (1) DE69131895T2 (de)
DK (1) DK0539420T3 (de)
ES (1) ES2142802T3 (de)
FI (1) FI102753B1 (de)
GR (1) GR3032999T3 (de)
HU (1) HU221298B1 (de)
IE (1) IE912533A1 (de)
IL (1) IL98865A (de)
MX (1) MX9100307A (de)
NO (1) NO304791B1 (de)
NZ (1) NZ238863A (de)
PH (1) PH31063A (de)
PL (1) PL170580B1 (de)
PT (1) PT98366B (de)
RU (1) RU2067978C1 (de)
SK (1) SK280690B6 (de)
TW (1) TW209217B (de)
WO (1) WO1992001697A1 (de)
ZA (1) ZA915654B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
WO2001000615A1 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
CA2376781A1 (en) * 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Benzimidazoles and imidazopyridines as respiratory syncytial virus replication inhibitors
AU778218B2 (en) * 1999-06-28 2004-11-25 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
MXPA05007485A (es) 2003-01-14 2006-01-30 Arena Pharm Inc Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
DE602005019874D1 (de) * 2004-05-12 2010-04-22 Bristol Myers Squibb Co Für die behandlung von thrombotischen leiden geeignete harnstoffantagonisten des p2y1-rezeptors
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
CN103539791B (zh) 2010-09-22 2017-01-11 艾尼纳制药公司 Gpr119 受体调节剂和对与其相关的障碍的治疗
EP3040334A1 (de) * 2014-12-29 2016-07-06 Faes Farma, S.A. Neue Benzimidazolderivate als Antihistaminmittel
JP6895378B2 (ja) 2015-01-06 2021-06-30 アリーナ ファーマシューティカルズ, インコーポレイテッド S1p1受容体に関連する状態の処置方法
MA42807A (fr) 2015-06-22 2018-07-25 Arena Pharm Inc Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
US4695569A (en) * 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
US4695575A (en) * 1984-11-13 1987-09-22 Janssen Pharmaceutica, N.V. 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines
GB8515934D0 (en) * 1985-06-24 1985-07-24 Janssen Pharmaceutica Nv (4-piperidinomethyl and-hetero)purines
US4835161A (en) * 1986-02-03 1989-05-30 Janssen Pharmaceutica N.V. Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
DE3701863A1 (de) * 1987-01-23 1988-08-04 Standard Elektrik Lorenz Ag Sender zur kohaerent optischen nachrichtenuebertragung
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
GB8900380D0 (en) * 1989-01-09 1989-03-08 Janssen Pharmaceutica Nv 2-aminopyrimidinone derivatives

Also Published As

Publication number Publication date
ES2142802T3 (es) 2000-05-01
GR3032999T3 (en) 2000-07-31
CS223991A3 (en) 1992-02-19
DE69131895T2 (de) 2000-07-20
WO1992001697A1 (en) 1992-02-06
NO304791B1 (no) 1999-02-15
NO930139D0 (no) 1993-01-15
NO930139L (no) 1993-01-15
IL98865A (en) 1995-11-27
MX9100307A (es) 1992-02-28
SK280690B6 (sk) 2000-06-12
CN1058216A (zh) 1992-01-29
TW209217B (de) 1993-07-11
IL98865A0 (en) 1992-07-15
PT98366A (pt) 1992-05-29
JP3085707B2 (ja) 2000-09-11
FI102753B (fi) 1999-02-15
FI930199A0 (fi) 1993-01-18
KR100206723B1 (ko) 1999-07-01
PL297612A1 (de) 1992-07-13
PH31063A (en) 1998-02-05
RU2067978C1 (ru) 1996-10-20
PT98366B (pt) 1999-01-29
PL170580B1 (pl) 1997-01-31
AU646280B2 (en) 1994-02-17
IE912533A1 (en) 1992-01-29
ZA915654B (en) 1993-03-31
DK0539420T3 (da) 2000-05-29
ATE188477T1 (de) 2000-01-15
CZ279903B6 (cs) 1995-08-16
HUT64066A (en) 1993-11-29
CN1037770C (zh) 1998-03-18
HU221298B1 (en) 2002-09-28
JPH05508638A (ja) 1993-12-02
AU8209391A (en) 1992-02-18
NZ238863A (en) 1993-03-26
FI930199A (fi) 1993-01-18
CA2086546A1 (en) 1992-01-20
HU9300096D0 (en) 1993-04-28
EP0539420A1 (de) 1993-05-05
FI102753B1 (fi) 1999-02-15
EP0539420B1 (de) 2000-01-05

Similar Documents

Publication Publication Date Title
ATE188477T1 (de) Substituierte thiazol- und pyridinderivate
ES2059489T3 (es) Derivados bencimidazol 1-alkil sustituidos.
ATE107642T1 (de) 2-aminopyrimidinon-derivate.
DK0393738T3 (da) Hydroxyalkylfuranylderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee